What Is the Institutional Investor Profile of Arch Capital (ACGL)?

Arch Capital stock is trading -10.39% below its average target price of $69.7 after dropping -1.5% during today's afternoon session. Analysts are giving the large-cap Diversified Insurance company an average rating of buy and target prices ranging from $65 to $75 per share.

The stock has an average amount of shares sold short at 2.3%, and a short ratio of 4.17. The company's insiders own 3.08% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 92.2% of Arch Capital's shares being owned by this investor type.

Institutions Invested in Arch Capital

Holder Shares Date Reported Percentage Value
Artisan Partners Limited Partnership 35,253,620 2022-09-29 10% $2,201,941,072
Vanguard Group, Inc. (The) 34,055,507 2022-09-29 9% $2,127,106,936
BAMCO Inc. 21,493,024 2022-09-29 6% $1,342,454,259
Capital World Investors 19,211,762 2022-09-29 5% $1,199,966,636
Blackrock Inc. 17,904,783 2022-09-29 5% $1,118,332,729
Allspring Global Investments Holdings, LLC 10,483,089 2022-09-29 3% $654,773,729
Capital Research Global Investors 9,697,564 2022-09-29 3% $605,709,838
FPR Partners, LLC 9,161,738 2022-09-29 2% $572,242,147
State Street Corporation 8,149,909 2022-09-29 2% $509,043,308
Wellington Management Group, LLP 7,456,869 2022-09-29 2% $465,756,030

Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Arch Capital.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.